303 related articles for article (PubMed ID: 10478858)
1. Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure.
Liu Y; Liu J; Habeebu SS; Klaassen CD
Toxicol Sci; 1999 Aug; 50(2):221-7. PubMed ID: 10478858
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of MT-null mice to chronic CdCl2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex.
Liu J; Liu Y; Habeebu SS; Klaassen CD
Toxicol Sci; 1998 Nov; 46(1):197-203. PubMed ID: 9928683
[TBL] [Abstract][Full Text] [Related]
3. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
Liu J; Habeebu SS; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
Liu J; Liu Y; Michalska AE; Choo KH; Klaassen CD
J Pharmacol Exp Ther; 1996 Mar; 276(3):1216-23. PubMed ID: 8786554
[TBL] [Abstract][Full Text] [Related]
5. Protection by zinc-metallothionein (ZnMT) against cadmium-metallothionein-induced nephrotoxicity.
Dorian C; Klaassen CD
Fundam Appl Toxicol; 1995 Jun; 26(1):99-106. PubMed ID: 7657068
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein-I/II null mice are sensitive to chronic oral cadmium-induced nephrotoxicity.
Liu Y; Liu J; Habeebu SM; Waalkes MP; Klaassen CD
Toxicol Sci; 2000 Sep; 57(1):167-76. PubMed ID: 10966523
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-I-transgenic mice are not protected from acute cadmium-metallothionein-induced nephrotoxicity.
Liu YP; Liu J; Palmiter RD; Klaassen CD
Toxicol Appl Pharmacol; 1996 Apr; 137(2):307-15. PubMed ID: 8661357
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
Dorian C; Gattone VH; Klaassen CD
Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
[TBL] [Abstract][Full Text] [Related]
9. Kidney synthesizes less metallothionein than liver in response to cadmium chloride and cadmium-metallothionein.
Sendelbach LE; Klaassen CD
Toxicol Appl Pharmacol; 1988 Jan; 92(1):95-102. PubMed ID: 3341030
[TBL] [Abstract][Full Text] [Related]
10. Chronic combined exposure to cadmium and arsenic exacerbates nephrotoxicity, particularly in metallothionein-I/II null mice.
Liu J; Liu Y; Habeebu SM; Waalkes MP; Klaassen CD
Toxicology; 2000 Jul; 147(3):157-66. PubMed ID: 10924798
[TBL] [Abstract][Full Text] [Related]
11. Cadmium accumulation and metallothionein concentrations after 4-week dietary exposure to cadmium chloride or cadmium-metallothionein in rats.
Groten JP; Sinkeldam EJ; Luten JB; van Bladeren PJ
Toxicol Appl Pharmacol; 1991 Dec; 111(3):504-13. PubMed ID: 1746026
[TBL] [Abstract][Full Text] [Related]
12. Nephrotoxicity of cadmium-metallothionein: protection by zinc and role of glutathione.
Tang W; Sadovic S; Shaikh ZA
Toxicol Appl Pharmacol; 1998 Aug; 151(2):276-82. PubMed ID: 9707504
[TBL] [Abstract][Full Text] [Related]
13. Modulation of calciuria by cadmium pretreatment in rats with cadmium-metallothionein-induced nephrotoxicity.
Jin T; Nordberg M; Nordberg GF
Toxicology; 1992 Oct; 75(1):29-37. PubMed ID: 1360715
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity.
Klaassen CD; Liu J
J Toxicol Sci; 1998 Jul; 23 Suppl 2():97-102. PubMed ID: 9760441
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein-null mice are more susceptible than wild-type mice to chronic CdCl(2)-induced bone injury.
Habeebu SS; Liu J; Liu Y; Klaassen CD
Toxicol Sci; 2000 Jul; 56(1):211-9. PubMed ID: 10869470
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity of CdCl2 and Cd-metallothionein in cultured rat kidney proximal tubules and LLC-PK1 cells.
Liu J; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1994 Oct; 128(2):264-70. PubMed ID: 7940541
[TBL] [Abstract][Full Text] [Related]
17. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
Squibb KS; Pritchard JB; Fowler BA
J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals.
Liu J; Liu Y; Goyer RA; Achanzar W; Waalkes MP
Toxicol Sci; 2000 Jun; 55(2):460-7. PubMed ID: 10828279
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium.
Habeebu SS; Liu J; Liu Y; Klaassen CD
Toxicol Sci; 2000 May; 55(1):223-32. PubMed ID: 10788577
[TBL] [Abstract][Full Text] [Related]
20. Renal cadmium deposition and injury as a result of accumulation of cadmium-metallothionein (CdMT) by the proximal convoluted tubules--A light microscopic autoradiography study with 109CdMT.
Dorian C; Gattone VH; Klaasen CD
Toxicol Appl Pharmacol; 1992 Jun; 114(2):173-81. PubMed ID: 1609408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
